Elicio Therapeutics, Inc. SEC filings ELTX
Elicio Therapeutics, Inc. has 384 filings in SEC EDGAR's recent list, going back to Mar 4, 2014. Its latest annual report, Form 10-K, was filed on Mar 12, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Nov 5, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Results of operations
|
Nov 5, 2026 | Nov 5, 2026 |
| DEF 14A | Proxy statement | Oct 9, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Other events
|
Sep 14, 2026 | Sep 14, 2026 |
| 4 | Insider transaction | Sep 2, 2026 | Aug 31, 2026 |
| 4 | Insider transaction | Sep 2, 2026 | Aug 31, 2026 |
| 4 | Insider transaction | Sep 2, 2026 | Aug 31, 2026 |
| 4 | Insider transaction | Sep 2, 2026 | Aug 31, 2026 |
| 4 | Insider transaction | Sep 2, 2026 | Aug 31, 2026 |
| 4 | Insider transaction | Sep 2, 2026 | Aug 31, 2026 |
| 4 | Insider transaction | Sep 2, 2026 | Aug 31, 2026 |
| 10-Q | Quarterly report | Aug 13, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 13, 2026 | Aug 13, 2026 |
| 4 | Insider transaction | Jul 17, 2026 | Jul 16, 2026 |
| 4 | Insider transaction | Jul 17, 2026 | Jul 16, 2026 |
| 4 | Insider transaction | Jul 17, 2026 | Jul 16, 2026 |
| 4 | Insider transaction | Jul 17, 2026 | Jul 16, 2026 |
| SCHEDULE 13G | Ownership over 5% (passive) | Jul 16, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Jul 8, 2026 | — |
| 424B5 | Prospectus supplement | Jul 2, 2026 | — |
| 8-K |
Current report
Material agreement, Other events
|
Jul 2, 2026 | Jul 1, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 24, 2026 | Jun 24, 2026 |
| 8-K |
Current report
Other events
|
Jun 17, 2026 | Jun 17, 2026 |
| 8-K |
Current report
Other events
|
Jun 15, 2026 | Jun 15, 2026 |
| 10-Q | Quarterly report | May 11, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Results of operations
|
May 11, 2026 | May 11, 2026 |
| 10-K/A | Amended annual report | Apr 29, 2026 | Dec 31, 2025 |
| EFFECT | Filing | Mar 16, 2026 | — |
| 8-K |
Current report
Material agreement, Agreement ended
|
Mar 16, 2026 | Mar 16, 2026 |
| 424B5 | Prospectus supplement | Mar 16, 2026 | — |
| S-8 | Employee stock plan registration | Mar 12, 2026 | — |
| CORRESP | Letter to the SEC | Mar 12, 2026 | — |
| S-3/A | Filing | Mar 12, 2026 | — |
| 10-K | Annual report | Mar 12, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Results of operations
|
Mar 12, 2026 | Mar 12, 2026 |
| UPLOAD | Letter from the SEC | Mar 6, 2026 | — |
| S-3/A | Filing | Mar 2, 2026 | — |
| S-3 | Shelf registration | Feb 27, 2026 | — |
| 4 | Insider transaction | Feb 3, 2026 | Feb 2, 2026 |
| 4 | Insider transaction | Feb 3, 2026 | Feb 2, 2026 |
| 4 | Insider transaction | Feb 3, 2026 | Feb 2, 2026 |
| 4 | Insider transaction | Feb 3, 2026 | Feb 2, 2026 |
| 4 | Insider transaction | Dec 10, 2025 | Dec 9, 2025 |
| EFFECT | Filing | Dec 3, 2025 | — |
| CORRESP | Letter to the SEC | Dec 1, 2025 | — |
| S-3 | Shelf registration | Nov 13, 2025 | — |
| 10-Q | Quarterly report | Nov 13, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 13, 2025 | Nov 13, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Oct 7, 2025 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Sep 17, 2025 | Sep 17, 2025 |
| 8-K |
Current report
Other events
|
Aug 12, 2025 | Aug 12, 2025 |
| 10-Q | Quarterly report | Aug 7, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Results of operations
|
Aug 7, 2025 | Aug 7, 2025 |
| 8-K |
Current report
Other events
|
Aug 5, 2025 | Aug 5, 2025 |
| 4 | Insider transaction | Jun 4, 2025 | Jun 3, 2025 |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Jun 4, 2025 | — |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale, Regulation FD disclosure
|
Jun 4, 2025 | Jun 4, 2025 |
| 4 | Insider transaction | May 20, 2025 | May 19, 2025 |
| 4 | Insider transaction | May 20, 2025 | May 19, 2025 |
| 4 | Insider transaction | May 20, 2025 | May 19, 2025 |
| 4 | Insider transaction | May 20, 2025 | May 19, 2025 |
| 4 | Insider transaction | May 20, 2025 | May 19, 2025 |
| 4 | Insider transaction | May 20, 2025 | May 19, 2025 |
| 4 | Insider transaction | May 20, 2025 | May 19, 2025 |
| 8-K |
Current report
Shareholder vote results
|
May 20, 2025 | May 19, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 14, 2025 | — |
| 10-Q | Quarterly report | May 13, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Results of operations
|
May 13, 2025 | May 13, 2025 |
| 4 | Insider transaction | Apr 16, 2025 | Apr 15, 2025 |
| ARS | Annual report to shareholders | Apr 9, 2025 | Dec 31, 2024 |
| DEF 14A | Proxy statement | Apr 9, 2025 | Apr 9, 2025 |
| 3 | Initial insider ownership | Apr 2, 2025 | Mar 24, 2025 |
| S-8 | Employee stock plan registration | Mar 31, 2025 | — |
| 10-K | Annual report | Mar 31, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Results of operations
|
Mar 31, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Officer or director change
|
Mar 24, 2025 | Mar 21, 2025 |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Mar 7, 2025 | — |
| 4 | Insider transaction | Mar 7, 2025 | Mar 5, 2025 |
| 8-K |
Current report
Unregistered share sale
|
Mar 5, 2025 | Mar 5, 2025 |
| SCHEDULE 13G | Ownership over 5% (passive) | Feb 5, 2025 | — |
| 4 | Insider transaction | Feb 4, 2025 | Feb 3, 2025 |
| 4 | Insider transaction | Feb 4, 2025 | Feb 3, 2025 |
| 4 | Insider transaction | Feb 4, 2025 | Feb 3, 2025 |
| 8-K |
Current report
Material agreement, Other events
|
Jan 30, 2025 | Jan 29, 2025 |
| 424B5 | Prospectus supplement | Jan 30, 2025 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 23, 2025 | Jan 23, 2025 |
| 8-K |
Current report
Other events
|
Jan 22, 2025 | Jan 22, 2025 |
| SCHEDULE 13G | Ownership over 5% (passive) | Jan 7, 2025 | — |
| 4/A | Form 4/a | Jan 2, 2025 | Jun 28, 2024 |
| 4 | Insider transaction | Dec 18, 2024 | Dec 16, 2024 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Dec 12, 2024 | Dec 12, 2024 |
| 8-K |
Current report
Other events
|
Dec 3, 2024 | Dec 3, 2024 |
| 4 | Insider transaction | Nov 29, 2024 | Nov 26, 2024 |
| 4 | Insider transaction | Nov 25, 2024 | Nov 21, 2024 |
| 4 | Insider transaction | Nov 25, 2024 | Nov 21, 2024 |
| 4 | Insider transaction | Nov 25, 2024 | Nov 21, 2024 |
| 4 | Insider transaction | Nov 25, 2024 | Nov 21, 2024 |
| 4 | Insider transaction | Nov 25, 2024 | Nov 21, 2024 |
| 4 | Insider transaction | Nov 25, 2024 | Nov 21, 2024 |
| 4 | Insider transaction | Nov 25, 2024 | Nov 21, 2024 |
| 424B3 | Prospectus | Nov 22, 2024 | — |
| 8-K |
Current report
Shareholder vote results
|
Nov 21, 2024 | Nov 21, 2024 |
| EFFECT | Filing | Nov 20, 2024 | — |
| CORRESP | Letter to the SEC | Nov 18, 2024 | — |
| UPLOAD | Letter from the SEC | Nov 15, 2024 | — |
| S-3 | Shelf registration | Nov 13, 2024 | — |
| 10-Q | Quarterly report | Nov 13, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Results of operations
|
Nov 13, 2024 | Nov 13, 2024 |
| 8-K |
Current report
Other events
|
Nov 7, 2024 | Nov 7, 2024 |
| 8-K |
Current report
Other events
|
Nov 7, 2024 | Nov 7, 2024 |
| 8-K |
Current report
Officer or director change
|
Oct 17, 2024 | Oct 15, 2024 |
| 4 | Insider transaction | Oct 2, 2024 | Sep 30, 2024 |
| 4 | Insider transaction | Oct 2, 2024 | Sep 30, 2024 |
| 4 | Insider transaction | Oct 2, 2024 | Sep 30, 2024 |
| ARS | Annual report to shareholders | Sep 27, 2024 | Dec 31, 2023 |
| DEF 14A | Proxy statement | Sep 27, 2024 | Nov 7, 2024 |
| PRE 14A | Preliminary proxy statement | Sep 17, 2024 | Nov 7, 2024 |
| 8-K |
Current report
Officer or director change
|
Aug 30, 2024 | Aug 27, 2024 |
| SC 13D/A | Amended ownership over 5% (active) | Aug 14, 2024 | — |
| 4 | Insider transaction | Aug 14, 2024 | Aug 12, 2024 |
| 10-Q | Quarterly report | Aug 13, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Results of operations
|
Aug 13, 2024 | Aug 13, 2024 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale, Other events
|
Aug 12, 2024 | Aug 12, 2024 |
| 4 | Insider transaction | Jul 2, 2024 | Jun 28, 2024 |
| SC 13D/A | Amended ownership over 5% (active) | Jul 2, 2024 | — |
| 4 | Insider transaction | Jul 2, 2024 | Jun 28, 2024 |
| 424B5 | Prospectus supplement | Jul 1, 2024 | — |
| 8-K |
Current report
Material agreement, Other events
|
Jul 1, 2024 | Jun 28, 2024 |
| 424B5 | Prospectus supplement | Jun 27, 2024 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jun 27, 2024 | Jun 27, 2024 |
| EFFECT | Filing | Jun 11, 2024 | — |
| EFFECT | Filing | Jun 11, 2024 | — |
| CORRESP | Letter to the SEC | Jun 10, 2024 | — |
| CORRESP | Letter to the SEC | Jun 7, 2024 | — |
| UPLOAD | Letter from the SEC | Jun 6, 2024 | — |
| S-3 | Shelf registration | Jun 3, 2024 | — |
| CORRESP | Letter to the SEC | Jun 3, 2024 | — |
| S-3/A | Filing | Jun 3, 2024 | — |
| 8-K |
Current report
Other events
|
May 24, 2024 | May 23, 2024 |
| 10-Q | Quarterly report | May 15, 2024 | Mar 31, 2024 |
| 8-K |
Current report
Results of operations
|
May 15, 2024 | May 15, 2024 |
| 10-K/A | Amended annual report | Apr 29, 2024 | Dec 31, 2023 |
| SC 13D/A | Amended ownership over 5% (active) | Apr 10, 2024 | — |
| UPLOAD | Letter from the SEC | Apr 10, 2024 | — |
| 8-K |
Current report
Other events
|
Apr 5, 2024 | Apr 5, 2024 |
| S-8 | Employee stock plan registration | Mar 29, 2024 | — |
| S-3 | Shelf registration | Mar 29, 2024 | — |
| 10-K | Annual report | Mar 29, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Results of operations
|
Mar 29, 2024 | Mar 29, 2024 |
| D | Filing | Mar 29, 2024 | — |
| SC 13D/A | Amended ownership over 5% (active) | Mar 20, 2024 | — |
| SC 13D/A | Amended ownership over 5% (active) | Mar 20, 2024 | — |
| 4 | Insider transaction | Mar 20, 2024 | Mar 19, 2024 |
| 8-K |
Current report
Material agreement
|
Mar 18, 2024 | Mar 18, 2024 |
| 4 | Insider transaction | Feb 5, 2024 | Feb 1, 2024 |
| 4 | Insider transaction | Feb 5, 2024 | Feb 1, 2024 |
| 4 | Insider transaction | Feb 5, 2024 | Feb 1, 2024 |
| 4 | Insider transaction | Feb 5, 2024 | Feb 1, 2024 |
| 8-K |
Current report
Officer or director change
|
Feb 2, 2024 | Feb 1, 2024 |
| 8-K |
Current report
Other events
|
Jan 17, 2024 | Jan 17, 2024 |
| 8-K |
Current report
Other events
|
Jan 16, 2024 | Jan 16, 2024 |
| 8-K |
Current report
Other events
|
Jan 9, 2024 | Jan 9, 2024 |
| D | Filing | Jan 5, 2024 | — |
| 4 | Insider transaction | Dec 29, 2023 | Dec 28, 2023 |
| 4 | Insider transaction | Dec 29, 2023 | Dec 28, 2023 |
| 4 | Insider transaction | Dec 29, 2023 | Dec 28, 2023 |
| 4 | Insider transaction | Dec 29, 2023 | Dec 28, 2023 |
| 4 | Insider transaction | Dec 29, 2023 | Dec 28, 2023 |
| 4 | Insider transaction | Dec 29, 2023 | Dec 28, 2023 |
| 4 | Insider transaction | Dec 29, 2023 | Dec 28, 2023 |
| SC 13D/A | Amended ownership over 5% (active) | Dec 27, 2023 | — |
| 4 | Insider transaction | Dec 26, 2023 | Dec 22, 2023 |
| SC 13D/A | Amended ownership over 5% (active) | Dec 26, 2023 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale, Other events
|
Dec 22, 2023 | Dec 22, 2023 |
| 10-Q | Quarterly report | Nov 13, 2023 | Sep 30, 2023 |
| 8-K |
Current report
Results of operations
|
Nov 9, 2023 | Nov 9, 2023 |
| 8-K |
Current report
Other events
|
Nov 3, 2023 | Nov 3, 2023 |
| 8-K |
Current report
Officer or director change
|
Oct 20, 2023 | Oct 19, 2023 |
| 8-K |
Current report
Officer or director change
|
Oct 12, 2023 | Oct 5, 2023 |
| 8-K |
Current report
Other events
|
Sep 28, 2023 | Sep 27, 2023 |
| 8-K |
Current report
Other events
|
Sep 7, 2023 | Sep 7, 2023 |
| SC 13D/A | Amended ownership over 5% (active) | Aug 30, 2023 | — |
| 8-K |
Current report
Officer or director change
|
Aug 30, 2023 | Aug 28, 2023 |
| S-8 | Employee stock plan registration | Aug 21, 2023 | — |
| 8-K/A | Amended current report | Aug 14, 2023 | May 31, 2023 |
| 10-Q | Quarterly report | Aug 14, 2023 | Jun 30, 2023 |
| 8-K |
Current report
Results of operations
|
Aug 11, 2023 | Aug 11, 2023 |
| SC 13G/A | Amended ownership over 5% (passive) | Jul 7, 2023 | — |
| SC 13D/A | Amended ownership over 5% (active) | Jun 14, 2023 | — |
| SC 13D | Ownership over 5% (active) | Jun 14, 2023 | — |
| 3 | Initial insider ownership | Jun 12, 2023 | Jun 1, 2023 |
| 3 | Initial insider ownership | Jun 12, 2023 | Jun 1, 2023 |
| SC 13D | Ownership over 5% (active) | Jun 12, 2023 | — |
| 3 | Initial insider ownership | Jun 7, 2023 | Jun 1, 2023 |
| 3 | Initial insider ownership | Jun 7, 2023 | Jun 1, 2023 |
| 3 | Initial insider ownership | Jun 7, 2023 | Jun 1, 2023 |
| 3 | Initial insider ownership | Jun 7, 2023 | Jun 1, 2023 |
| 3 | Initial insider ownership | Jun 7, 2023 | Jun 1, 2023 |
| 3 | Initial insider ownership | Jun 7, 2023 | Jun 1, 2023 |
| 3 | Initial insider ownership | Jun 7, 2023 | Jun 1, 2023 |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- ELTX (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Boston, MA
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1601485
- Former names
- Angion Biomedica Corp. (until May 30, 2023)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.